Join Here   |   Log In

Fibroids: Genes, Root Causes, and Solutions

Key takeaways:
~ Uterine fibroids are benign tumors that grow in the muscle cells of the uterus.
~ While estimates vary, at least half of American women who are of reproductive age have fibroids.[ref]
~ Genetic variants related to estrogen metabolism, vascular growth, and detoxification all increase the odds of having fibroids.
~ Environmental exposure to endocrine disruptors increases the risk and growth of fibroids.

This article digs into the causes of fibroids, explains how your genetic variants can add to the susceptibility, and offers solutions backed by research.

Members will see their genotype report below and the solutions in the Lifehacks section. Consider joining today

Uterine fibroids:

Symptoms of fibroids include:

  • Painful or heavy periods
  • Anemia (due to heavy periods)
  • Frequent need to urinate
  • Painful sex
  • Low back pain

Fibroids can also play a role in infertility for some women.

Not all women have symptoms with fibroids – it depends on the location and size.

What is a fibroid? Uterine leiomyoma, another name for fibroids, means smooth muscle tumor. It is a benign growth in the uterus.

Causes of fibroids

You would think that something that affects more than half of women would be well understood and have good solutions available. Oddly enough, there are still questions surrounding the causes of fibroids, and a lot of the solutions available are either ineffective or come with significant side effects.

Genes and Lifestyle:
Genetics plays a role in the susceptibility to fibroids, but, as you will see, lifestyle factors are also important.[ref]

Stem cells and growth

Fibroids are medically classified as benign tumors, meaning they are nearly always non-cancerous growths.

Genetic studies show that a fibroid will arise from one cell that has somewhat unchecked growth. Stem cells are present in the muscles of the uterus, which need to be able to grow and change both monthly and during pregnancy.[ref][ref]

The stem cells in the uterine muscles are capable of replicating into more muscle tissue – that is their whole purpose. When there is DNA damage in a growth-related gene, the stem cells go on a growth spree and become fibroids. Additionally, the conditions for growth and proliferation of the cells need to be right (see below). The body’s normal way of dealing with damaged DNA also needs to be overridden.[ref]

Estrogen, progesterone, and growth

Estrogen and progesterone are involved in the formation and growth of fibroids, which occur mainly during the reproductive years when estrogen and progesterone levels are high. Fibroids usually decrease in size once a woman reaches menopause.

The cells in a fibroid have increased estrogen and progesterone receptors. Animal studies show that the addition of estrogen alone, or estrogen plus progesterone, can increase the size of fibroids.[ref]

In the uterus, estrogen upregulates IFG-1 (insulin-like growth factor 1), EGFR, TGF-beta1. These are all growth-related molecules.[ref]

Interleukin-1 (IL-1) is an inflammatory cytokine that can inhibit REST, which is a tumor suppressor. Interleukin-1 also happens to be upregulated in fibroid tissue, thus decreasing the tumor suppressor.[ref]

Exposure to endocrine disruptors

Adding fuel to the fibroid fire, exposure to endocrine-disrupting chemicals such as BPA and phthalates also increases the risk and growth of fibroids.

BPA is a component of plastics and a known endocrine disruptor, similar in structure to estrogen. A cell study shows that exposure to low levels of BPA increases the proliferation of fibroid cells.[ref] A study of 495 women who were diagnosed with fibroids found that they had higher concentrations of BPA in them than women without fibroids.[ref]

2-hydroxy-4-methoxybenzophenone, a UV filter found in sunscreens, has links to an increase in fibroids.[ref]

Phthalates, found in plastics, vinyl, and artificial fragrances, act as endocrine-disrupting chemicals and have links to an increased risk of fibroids. This was especially true in women who carried the GSTM1 null genotype.[ref]

In fact, a 2022 study found that higher exposure to phthalates increased the growth of fibroids. The researcher found that phthalate metabolites increased tryptophan and kynurenine levels as well as activated the aryl hydrocarbon receptor in fibroid cells.[ref]

In-utero and infant exposures to DES

Early-onset fibroids are linked to exposure to diethylstilbestrol (DES) in utero. DES, an estrogen medication, was used from 1940 to 1971 for pregnant women. The daughters of women who took DES were at a higher risk for fibroids at a younger age.[ref]

Microplastics:

Microplastics are microscopic particles of plastic that are ubiquitous in our modern food supply, water, and even air. Microplastics are both a source of inflammation (foreign particle) as well as giving off endocrine-disrupting chemicals.

A 2024 study showed that microplastic particles are found in uterine fibroids. The study showed that all 16 samples of fibroids contained microplastics and that there was a higher quantity of microplastics in the myometrium tissue of women with fibroids compared to a control group without fibroids.[ref]

A 2024 preprint study also shows that microplastics are found in the follicular fluid in the ovaries. The study involved 18 women undergoing reproductive help, and found that 75% had significant amounts of microplastic particles in their ovaries.[ref]

Viral infection:

Infection with cytomegalovirus in the uterine tissue leads to an associated 6-fold increase in the risk of fibroids. On the other hand, Chlamydia trachomatis decreased the risk of fibroids.[ref][ref]


Fibroids Genotype Report:

Members: Log in to see your data below.
Not a member? Join here.


Access this content:

An active subscription is required to access this content.

Join as a member


 


Lifehacks: Natural solutions for fibroids

Diet changes to prevent fibroids

Women eating >2 servings of fruits per day had a slightly decreased risk of uterine fibroids compared to women eating less than 2 servings per week. A higher intake of animal sources of vitamin A seems linked to a slightly decreased risk of uterine fibroids.[ref]

Another study found that frequent milk and soybean use was linked with an increased risk of fibroids.[ref] Unfortunately, the study lumped both of those together as a category, so I’m not sure which one was important. The implication here is that additional phytoestrogens or bovine hormones could increase fibroids. Since most dairy now has no added hormones, my guess is that the phytoestrogens in soy were the main culprit.

Food additives, sweeteners, and preserved foods have links to an increased risk of fibroids. (Not really helpful since the study doesn’t really narrow down or define those terms.)[ref]

Oral contraceptive use has links to an increased risk of fibroids.[ref] Alternatively, some types of oral contraceptives can also be used to slow menstrual bleeding and decrease the symptoms of fibroids. Talk with your gynecologist on this one.

Avoid phthalates and BPA:

Phthalates are a chemical found in plastics, vinyl, and artificial fragrances (personal care products, air fresheners, and laundry products). They act as estrogen mimics in the body. The level of phthalate metabolites is associated with the size of fibroids – more phthalates in the body = bigger fibroids.[ref][ref]

Similarly, higher BPA levels have links to increased odds of fibroids. BPA can be found in some plastics, household dust, and thermal printed receipts.

What can you realistically do to avoid phthalates and BPA? Check your personal care products for phthalates, and look for laundry products without artificial fragrances included. Regular dusting and vacuuming have been shown to decrease BPA. Handling thermal printed receipts, especially with wet hands, increases BPA fairly significantly in the body.

Related articles: Detoxification genetic pathways of phthalates and BPA

Reducing fibroids with natural supplements:

Access this content:

An active subscription is required to access this content.

Join as a member



Related Articles and Topics:

Thyroid Hormones: Genes, Hypothyroidism, and T4/T3 Conversion

Phthalates: Genes, Diet, and Detoxification Pathways


References:

Bray, Michael J., et al. “Estimating Uterine Fibroid SNP-Based Heritability in European American Women with Imaging-Confirmed Fibroids.” Human Heredity, vol. 84, no. 2, 2019, pp. 73–81. PubMed, https://doi.org/10.1159/000501335.
Burns, Katherine A., and Kenneth S. Korach. “Estrogen Receptors and Human Disease: An Update.” Archives of Toxicology, vol. 86, no. 10, Oct. 2012, pp. 1491–504. PubMed Central, https://doi.org/10.1007/s00204-012-0868-5.
Cai, Yi-Ran, et al. “X-Chromosomal Inactivation Analysis of Uterine Leiomyomas Reveals a Common Clonal Origin of Different Tumor Nodules in Some Multiple Leiomyomas.” International Journal of Oncology, vol. 31, no. 6, Dec. 2007, pp. 1379–89.
Chen, Hsin-Yuan, et al. “Natural Antioxidant Resveratrol Suppresses Uterine Fibroid Cell Growth and Extracellular Matrix Formation In Vitro and In Vivo.” Antioxidants, vol. 8, no. 4, Apr. 2019, p. 99. PubMed Central, https://doi.org/10.3390/antiox8040099.
Ciebiera, Michał, et al. “Alternative Oral Agents in Prophylaxis and Therapy of Uterine Fibroids—An Up-to-Date Review.” International Journal of Molecular Sciences, vol. 18, no. 12, Dec. 2017, p. 2586. PubMed Central, https://doi.org/10.3390/ijms18122586.
Commandeur, Arno E., et al. “Epidemiological and Genetic Clues for Molecular Mechanisms Involved in Uterine Leiomyoma Development and Growth.” Human Reproduction Update, vol. 21, no. 5, Sept. 2015, pp. 593–615. PubMed Central, https://doi.org/10.1093/humupd/dmv030.
D’Aloisio, Aimee A., et al. “Early-Life Exposures and Early-Onset Uterine Leiomyomata in Black Women in the Sister Study.” Environmental Health Perspectives, vol. 120, no. 3, Mar. 2012, pp. 406–12. PubMed, https://doi.org/10.1289/ehp.1103620.
Gao, Mei, and Hui Wang. “Frequent Milk and Soybean Consumption Are High Risks for Uterine Leiomyoma.” Medicine, vol. 97, no. 41, Oct. 2018, p. e12009. PubMed Central, https://doi.org/10.1097/MD.0000000000012009.
Gao, Min, et al. “Aspirin Inhibits the Proliferation of Human Uterine Leiomyoma Cells by Downregulation of K‑Ras‑p110α Interaction.” Oncology Reports, vol. 38, no. 4, Oct. 2017, pp. 2507–17. PubMed, https://doi.org/10.3892/or.2017.5915.
Hewitt, Sylvia C., et al. “Estrogen-Mediated Regulation of Igf1 Transcription and Uterine Growth Involves Direct Binding of Estrogen Receptor α to Estrogen-Responsive Elements.” The Journal of Biological Chemistry, vol. 285, no. 4, Jan. 2010, pp. 2676–85. PubMed Central, https://doi.org/10.1074/jbc.M109.043471.
Huang, Po-Chin, et al. “Association between Phthalate Exposure and Glutathione S-Transferase M1 Polymorphism in Adenomyosis, Leiomyoma and Endometriosis.” Human Reproduction (Oxford, England), vol. 25, no. 4, Apr. 2010, pp. 986–94. PubMed, https://doi.org/10.1093/humrep/deq015.
Iizuka, Takashi, et al. “Mono-(2-Ethyl-5-Hydroxyhexyl) Phthalate Promotes Uterine Leiomyoma Cell Survival through Tryptophan-Kynurenine-AHR Pathway Activation.” Proceedings of the National Academy of Sciences, vol. 119, no. 47, Nov. 2022, p. e2208886119. DOI.org (Crossref), https://doi.org/10.1073/pnas.2208886119.
Li, Yanxia, et al. “Mechanistic Study of the Inhibitory Effect of Kaempferol on Uterine Fibroids In Vitro.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, vol. 22, Dec. 2016, pp. 4803–08. PubMed Central, https://doi.org/10.12659/MSM.898127.
Liu, Xiaoqi, et al. “ESR1 PvuII (Rs2234693 T>C) Polymorphism and Cancer Susceptibility: Evidence from 80 Studies.” Journal of Cancer, vol. 9, no. 16, 2018, pp. 2963–72. PubMed, https://doi.org/10.7150/jca.25638.
Liu, Zhi-Qin, Mei-Yin Lu, et al. “Polymorphisms in XPC Gene and Risk of Uterine Leiomyoma in Reproductive Women.” Pathology Oncology Research: POR, vol. 26, no. 3, July 2020, pp. 1459–64. PubMed, https://doi.org/10.1007/s12253-019-00720-2.
Liu, Zhi-Qin, Guan-Ge Chen, et al. “XPG Rs873601 G>A Contributes to Uterine Leiomyoma Susceptibility in a Southern Chinese Population.” Bioscience Reports, vol. 38, no. 5, Oct. 2018, p. BSR20181116. PubMed, https://doi.org/10.1042/BSR20181116.
Malik, Minnie, et al. “Curcumin, a Nutritional Supplement with Antineoplastic Activity, Enhances Leiomyoma Cell Apoptosis and Decreases Fibronectin Expression.” Fertility and Sterility, vol. 91, no. 5 Suppl, May 2009, pp. 2177–84. PubMed, https://doi.org/10.1016/j.fertnstert.2008.03.045.
Moore, Kristen R., et al. “Chlamydia Trachomatis Seroprevalence and Ultrasound-Diagnosed Uterine Fibroids in a Large Population of Young African-American Women.” American Journal of Epidemiology, vol. 187, no. 2, Feb. 2018, pp. 278–86. PubMed, https://doi.org/10.1093/aje/kwx231.
Payson, Mark, et al. “Epidemiology of Myomas.” Obstetrics and Gynecology Clinics of North America, vol. 33, no. 1, Mar. 2006, pp. 1–11. PubMed, https://doi.org/10.1016/j.ogc.2005.12.004.
Pollack, AZ, et al. “Bisphenol A, Benzophenone-Type Ultraviolet Filters, and Phthalates in Relation to Uterine Leiomyoma.” Environmental Research, vol. 137, Feb. 2015, pp. 101–07. PubMed Central, https://doi.org/10.1016/j.envres.2014.06.028.
Prusinski Fernung, Lauren E., et al. “Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.” The American Journal of Pathology, vol. 188, no. 10, Oct. 2018, pp. 2293–306. PubMed, https://doi.org/10.1016/j.ajpath.2018.06.023.
Reding, Kerryn W., et al. “Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk.” Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 18, no. 5, May 2009, pp. 1461–67. PubMed, https://doi.org/10.1158/1055-9965.EPI-08-0917.
Roshdy, Eman, et al. “Treatment of Symptomatic Uterine Fibroids with Green Tea Extract: A Pilot Randomized Controlled Clinical Study.” International Journal of Women’s Health, vol. 5, Aug. 2013, pp. 477–86. PubMed Central, https://doi.org/10.2147/IJWH.S41021.
Saadatnia, Geita, et al. “Uterine Leiomyoma and Reproductive Tract Infections Detected by Polymerase Chain Reaction.” Iranian Journal of Pathology, vol. 14, no. 1, 2019, pp. 33–40. PubMed, https://doi.org/10.30699/IJP.14.1.33.
Salimi, Saeedeh, et al. “Cyclin D1 G870A Polymorphism: Association with Uterine Leiomyoma Risk and in Silico Analysis.” Biomedical Reports, vol. 6, no. 2, Feb. 2017, pp. 237–41. PubMed, https://doi.org/10.3892/br.2016.830.
Shen, Y., et al. “Environmental Exposure and Risk of Uterine Leiomyoma: An Epidemiologic Survey.” European Review for Medical and Pharmacological Sciences, vol. 17, no. 23, Dec. 2013, pp. 3249–56.
Shen, Yang, et al. “Role of Single Nucleotide Polymorphisms in Estrogen-Metabolizing Enzymes and Susceptibility to Uterine Leiomyoma in Han Chinese: A Case-Control Study.” The Journal of Obstetrics and Gynaecology Research, vol. 40, no. 4, Apr. 2014, pp. 1077–84. PubMed, https://doi.org/10.1111/jog.12275.
Weuve, Jennifer, et al. “Association of Exposure to Phthalates with Endometriosis and Uterine Leiomyomata: Findings from NHANES, 1999-2004.” Environmental Health Perspectives, vol. 118, no. 6, June 2010, pp. 825–32. PubMed, https://doi.org/10.1289/ehp.0901543.
Wise, Lauren A., Julie R. Palmer, et al. “FASN, Dietary Fat Intake, and Risk of Uterine Leiomyomata in the Black Women’s Health Study.” Fertility and Sterility, vol. 106, no. 5, Oct. 2016, pp. 1136–41. PubMed, https://doi.org/10.1016/j.fertnstert.2016.06.019.
Wise, Lauren A., Rose G. Radin, et al. “Intake of Fruit, Vegetables, and Carotenoids in Relation to Risk of Uterine Leiomyomata.” The American Journal of Clinical Nutrition, vol. 94, no. 6, Dec. 2011, pp. 1620–31. PubMed, https://doi.org/10.3945/ajcn.111.016600.
Xu, Hongwen, et al. “First Identification of Microplastics in Human Uterine Fibroids and Myometrium.” Environmental Pollution, vol. 360, Nov. 2024, p. 124632. ScienceDirect, https://doi.org/10.1016/j.envpol.2024.124632.
Yu, Linda, et al. “Bisphenol A Induces Human Uterine Leiomyoma Cell proliferation through Membrane-Associated ERα36 via Nongenomic Signaling.” Molecular and Cellular Endocrinology, vol. 484, Mar. 2019, pp. 59–68. PubMed Central, https://doi.org/10.1016/j.mce.2019.01.001.
Zota, Ami R., et al. “Phthalates Exposure and Uterine Fibroid Burden among Women Undergoing Surgical Treatment for Fibroids: A Preliminary Study.” Fertility and Sterility, vol. 111, no. 1, Jan. 2019, pp. 112–21. PubMed, https://doi.org/10.1016/j.fertnstert.2018.09.009.

About the Author:
Debbie Moon is a biologist, engineer, author, and the founder of Genetic Lifehacks where she has helped thousands of members understand how to apply genetics to their diet, lifestyle, and health decisions. With more than 10 years of experience translating complex genetic research into practical health strategies, Debbie holds a BS in engineering from Colorado School of Mines and an MSc in biological sciences from Clemson University. She combines an engineering mindset with a biological systems approach to explain how genetic differences impact your optimal health.